Skip to main content

News stories

New Medical Director for Good Hope Hospital

Published on 11/02/2025

Dr Pijush Ray will join Good Hope Hospital as its new Medical Director.
Dr Pijush Ray will join Good Hope Hospital as its new Medical Director.

We are pleased to announce that after a rigorous recruitment process, Dr Pijush Ray, currently Deputy Chief Medical Officer and Health Care of the Elderly Consultant at University Hospitals Coventry and Warwickshire NHS Trust, will join Good Hope Hospital as its new Medical Director.  

Dr Ray trained at the University of Calcutta, India, and qualified in 1987. He has specialty interests in frailty, dementia, delirium, general internal medicine, and geriatric medicine. He will join the Good Hope Hospital team on 17 February. 

Our previous Medical Director, Dr Khaled Elfandi is now based at Heartlands Hospital, having rejoined the Stroke team as a Consultant. 

We would like to extend our thanks and gratitude to Dr Elfandi who has been at the beating heart of Good Hope Hospital for many years. As well as being a key member of the hospital leadership team during COVID-19, where he supported colleagues both personally and professionally, he has worked closely with consultants and resident doctors to improve ways of working and their working environment, with patient safety at the forefront of everything he does. 
 
We would also like to thank Dr Srikar Peri who, with the support of Dr Chirag Dave, Dr Teresa Quigley and Mr Tiramula Raju, has provided medical leadership to Good Hope Hospital in the interim.

More news

Groundbreaking cancer treatment trial begins at QEHB

Groundbreaking cancer treatment trial begins at QEHB

A pioneering clinical trial offering new hope to melanoma patients has launched at Queen Elizabeth Hospital Birmingham (QEHB), with Kevin Hobbs, 34, from Telford becoming the first person in the West Midlands to receive the innovative treatment.
Pioneering trial to ensure arthritis treatment suitable for cancer immunotherapy patients

Pioneering trial to ensure arthritis treatment suitable for cancer immunotherapy patients

Cancer patients being treated with immunotherapy called checkpoint inhibitors often experience arthritis as a side effect. The first clinical trial of its kind in the UK is now open to test whether a powerful arthritis treatment is suitable for patients receiving ongoing cancer treatment.
Review led by researchers highlights potential treatment for alcohol use disorder

Review led by researchers highlights potential treatment for alcohol use disorder

University Hospitals Birmingham colleagues are among the authors of an international research paper recently published in The Lancet. Led by Dr Pouya Ebrahimi, Specialty Registrar in Cardiology, and Dr Yash Kachela, Medical Student Undergraduate, the study examines how diabetes and weight management medicines may support people living with alcohol use disorder.
Read more news